Abstract We report the case of a 32-year-old man from Rio de Janeiro, who was infected in the Amazon region of Brazil by Leishmania (Viannia) naiffi. Generally, patients with L. naiffi cutaneous leishmaniasis exhibit a good therapeutic response to either pentavalent antimonials or pentamidine. However, after pentamidine treatment, this patient’s infection evolved to therapeutic failure. To understand this clinical outcome, we investigated the presence of the Leishmania RNA virus (LRV) in parasites isolated from the cutaneous lesion; herein, we discuss the possible association between a poor response to pentamidine therapy and the presence of the LRV
The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength...
Abstract. The main causative agent of cutaneous leishmaniasis (CL) in Suriname is Leishmania (Vianni...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
This is a case report of a Brazilian soldier with cutaneous leishmaniasis. The lesion relapsed follo...
BACKGROUND Leishmania (Viannia) guyanensis is believed to be the principal cause of cutaneous leish...
Treatment failure and symptomatic relapse are major concerns in American tegumentary leishmaniasis (...
Abstract In Brazil, meglumine antimoniate is the first drug of choice for mucosal leishmaniasis trea...
International audienceTreatment failure and symptomatic relapse are major concerns in American tegum...
Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary l...
The clinical manifestations and prognosis of cutaneous leishmaniasis (CL) can be influenced by the i...
The main causative agent of cutaneous leishmaniasis (CL) in Suriname is Leishmania (Viannia) guyanen...
In the Brazilian Amazon, American tegumentary leishmaniasis (ATL) is endemic and presents a wide spe...
Leishmaniaparasites cause a broad range of disease, with cutaneous afflictions being, by far, the mo...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
In the Brazilian Amazon, American tegumentary leishmaniasis (ATL) is endemic and presents a wide spe...
The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength...
Abstract. The main causative agent of cutaneous leishmaniasis (CL) in Suriname is Leishmania (Vianni...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
This is a case report of a Brazilian soldier with cutaneous leishmaniasis. The lesion relapsed follo...
BACKGROUND Leishmania (Viannia) guyanensis is believed to be the principal cause of cutaneous leish...
Treatment failure and symptomatic relapse are major concerns in American tegumentary leishmaniasis (...
Abstract In Brazil, meglumine antimoniate is the first drug of choice for mucosal leishmaniasis trea...
International audienceTreatment failure and symptomatic relapse are major concerns in American tegum...
Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary l...
The clinical manifestations and prognosis of cutaneous leishmaniasis (CL) can be influenced by the i...
The main causative agent of cutaneous leishmaniasis (CL) in Suriname is Leishmania (Viannia) guyanen...
In the Brazilian Amazon, American tegumentary leishmaniasis (ATL) is endemic and presents a wide spe...
Leishmaniaparasites cause a broad range of disease, with cutaneous afflictions being, by far, the mo...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...
In the Brazilian Amazon, American tegumentary leishmaniasis (ATL) is endemic and presents a wide spe...
The treatment of Leishmaniasis caused by Leishmania (Viannia) guyanensis is based on a weak strength...
Abstract. The main causative agent of cutaneous leishmaniasis (CL) in Suriname is Leishmania (Vianni...
Background. Treatment for cutaneous leishmaniasis (CL) with standard pentavalent antimonial therapy ...